FDA approves quarterly siRNA for myasthenia gravis
-
By
-
Mouj Hijazi
-
November 19, 2026
-
2 min
By
Mouj Hijazi
November 19, 2026
None of the 3 symptomatic patients knew the injected product lacked FDA approval.
by Teraya Smith
October 9, 2026
Several FDA decisions across multiple specialties are expected this month.
July 30, 2026
A deadly conviction, healing vanilla, stormy lungs, and a COVID tea party await.
by Teraya Smith
October 15, 2026